{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:58:25Z","timestamp":1744736305335},"reference-count":10,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T00:00:00Z","timestamp":1152576000000},"content-version":"vor","delay-in-days":6066,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[1989,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>High\u2010dose cytosine arabinoside may benefit patients with refractory acute leukemia. Peripheral nervous system disturbances caused by cytosine arabinoside have rarely been reported. We describe a patient with acute leukemia who developed Horner's syndrome and a severe demyelinating peripheral neuropathy leading to death after receiving highdose cytosine arabinoside. Peripheral nerve dysfunction is a potentially serious complication of high\u2010dose cytosine arabinoside.<\/jats:p>","DOI":"10.1002\/ajh.2830320414","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T11:57:38Z","timestamp":1172059058000},"page":"314-315","source":"Crossref","is-referenced-by-count":13,"title":["Horner's syndrome and demyelinating peripheral neuropathy caused by high\u2010dose cytosine arabinoside"],"prefix":"10.1002","volume":"32","author":[{"given":"T. J.","family":"Nevill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. J.","family":"Benstead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. W.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. A.","family":"Hayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,11]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1182\/blood.V62.2.361.361","article-title":"High dose cytosine arabinoside therapy for refractory anemia","volume":"62","author":"Herzig RH","year":"1983","journal-title":"Blood"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19811215)48:12<2577::AID-CNCR2820481207>3.0.CO;2-Z"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830201)51:3<426::AID-CNCR2820510312>3.0.CO;2-S"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1200\/JCO.1986.4.1.95","article-title":"Peripheral neuropathy after high\u2010dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia","volume":"4","author":"Powell BL","year":"1986","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860815)58:4<852::AID-CNCR2820580408>3.0.CO;2-I"},{"key":"e_1_2_1_7_2","first-page":"103","article-title":"Neurotoxicity of antineoplastic drugs","volume":"9","author":"Kaplan RS","year":"1982","journal-title":"Semin Oncol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5945.652-b"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/96.1.69"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(58)90252-6"},{"key":"e_1_2_1_11_2","first-page":"93","article-title":"Guillain\u2010Barr\u00e9 syndrome: A 42\u2010year epidemiologic and clinical study","volume":"53","author":"Kennedy RH","year":"1978","journal-title":"Mayo Clin Proc"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.2830320414","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.2830320414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T06:32:29Z","timestamp":1697956349000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.2830320414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,12]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,12]]}},"alternative-id":["10.1002\/ajh.2830320414"],"URL":"https:\/\/doi.org\/10.1002\/ajh.2830320414","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,12]]}}}